More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/ELISA Kit for Anterior Gradient 2 (AGR2)

ELISA Kit for Anterior Gradient 2 (AGR2)

SEC285HU
Cloud-Clone Corp.
Product group Assays
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Cloud-Clone Corp.
  • Product Name
    ELISA Kit for Anterior Gradient 2 (AGR2)
  • Delivery Days Customer
    12
  • Assay Detection Range
    1.56-100ng/mL
  • Assay Precision
    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anterior Gradient 2 (AGR2) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and ...
  • Assay Sensitivity
    The minimum detectable dose of this kit is typically less than 0.55ng/mL
  • Assay Specificity
    This assay has high sensitivity and excellent specificity for detection of Anterior Gradient 2 (AGR2). No significant cross-reactivity or interference between Anterior Gradient 2 (AGR2) and analogues was observed.
  • Assay Test Principle
    The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Anterior Gradient 2 (AGR2). Standards or samples are then added to the appropriate ...
  • Assay Time
    3h
  • Certification
    Research Use Only
  • UNSPSC
    41116158

References

  • Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy-induced senescence escape. Maarouf A et al., 2022 Jan, Int J Oncol
    Read more
  • Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2). Garri C et al., 2018 Jun 8, Oncotarget
    Read more
  • AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection. Garczyk S et al., 2015, PLoS One
    Read more
  • Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. Chan A et al., 2014 Nov 15, Clin Cancer Res
    Read more
  • Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. Makawita S et al., 2013 Sep 3, BMC Cancer
    Read more
  • Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype. Kani K et al., 2013 Feb 15, Prostate
    Read more